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Introduction 
The demographic projections for the next half century have given rise to concerns that ageing 
may jeopardise the financial balances of European welfare systems. The impact of ageing on 
welfare spending is not homogeneous in all sectors, however. Specifically, the effects of ageing 
on health spending are rather uncertain.  
According to Evans et al. (2004), the risks for the health system’s sustainability associated with 
ageing have been greatly emphasised for political reasons: the claim that health expenditure will 
grow dramatically to meet increasing needs is a way to obtain more resources with which to 
increase the incomes of healthcare providers. At the same time, ageing may be used as 
justification for past increases in spending. This may detract attention from the actual causes of 
expenditure growth, from considerations concerning the appropriateness or effectiveness of care 
provision and from evaluation and accountability. Finally, the prediction that universal public 
healthcare systems will collapse strengthens the argument for a shift to a more mixed financing 
system, with a greater level of private payment. These and similar observations have prompted 
some experts to wonder whether the risk of huge health expenditure increases due to ageing is 
not a ‘red herring’ (see Zweifel et al., 1999, and the reply by Seshamani & Gray, 2004).  
These considerations highlight the complexity of health expenditure predictions and suggest the 
relevance of the political issues that lie behind certain technical aspects. For the reasons just 
given, the study of health costs prior to death may also help policy-making intended to curb 
expenditure and foster the efficiency of health systems.  
As recognised, the link between ageing and increases in health expenditure derives from the 
observation that the health consumption pattern by age displays a J-shaped curve, as per capita 
consumption continuously increases with age. It is thus easy to infer that ageing, in that it 
increases the share of the population in the old age groups, will generate a huge growth of 
healthcare spending. The concern about the future increase in health-care costs as a result of 
population ageing then mostly depends on the use of a static and constant age-related healthcare 
expenditure profile. But is it theoretically correct to assume the constancy of this profile, or does 
the age-related pattern change according to ageing as well?  
Research shows that the age profile changes for two main demographic reasons: the possible 
improvement in health status following the increase in life expectancy and the fact that the bulk 
of individual lifetime health-care costs are concentrated at the end of life (the so-called ‘death-
related’ costs).  
With regard to the death-costs factor, it has been suggested that the accelerated rise in costs at 
higher ages may not be a function of age per se, but rather of individual proximity to death, 
since age and death are closely correlated (hence the correlation between age and health-care 
costs may be – at least in part – a spurious one). In fact, it is unlikely that death costs are 2 | ENEPRI POLICY BRIEF NO. 5 
increased by ageing: rather, they are postponed, with a change in the health expenditure profile 
by age.  
The papers of AHEAD WP7 focus on the impact of death costs on health-care spending. 
Thorough examination should be made of these matters in order to obtain better understanding 
of the actual impact of ageing on the growth of health expenditure.  
The papers reviewed the empirical literature on health economics, presenting the main results 
obtained by studies on the interaction among age, proximity to death and health-care 
expenditure. Besides, they provide estimates of health expenditure by ‘distance from birth’ (i.e. 
age) and by ‘distance from death’ (i.e. the health expenditure incurred in the last period of life) 
in different parts of Italy. Specifically, we distinguish between ‘old age costs’ – healthcare 
expenditure due to the ageing of the population – and ‘death costs’ – healthcare expenditure due 
to the event of dying. Using the methodology proposed by Bartolacci et al. (2001), we estimate 
hospital costs prior to death in four regions (Tuscany, Lombardy, Abruzzi and Apulia).  
The results are then compared with previous estimates of healthcare expenditure by age and 
prior to death available for Italy. We compare the results with those of some other OECD 
countries as well.  
Methodology 
A review of the empirical literature on health economics - presenting the main results obtained 
by studies on the interaction among age, proximity to death and health-care expenditure - is 
included in the deliverables of WP7. The structure of this paper is based on a research strategy 
that classifies the studies depending on their main methodology (descriptive, econometric and 
forecasting), as shown in Table 1, which also displays the countries in which the impact of death 
costs has been studied and the analyses performed: 
•  descriptive studies, which evaluate the evolution of death costs by age and the ratio (at each 
age) between the health-care expenditures of decedents and survivors; 
•  econometric studies, which seek to estimate whether age and length of time to death are 
significant drivers of health-care expenditures; 
•  projection studies, which aim at calculating the difference between health-care cost 
projections that include or otherwise the death-costs assumption. 
It should be pointed out that empirical studies have focused mainly on healthcare costs (mostly 
on hospital care costs); only a few of them have examined long-term care as well.  
As for the analysis of the Italian case, we have to point out that the decentralisation of the Italian 
NHS increased the historical differences among regional health systems, with regions 
developing their own healthcare models. It also fostered fragmentation in the information 
system that is not easy to overcome. Hence, there is a lack of good quality data at national level, 
while at regional level they are sometimes of better quality – at least for hospital care.  
For the purpose of this study, a network of research institutes (ISAE and Mario Negri Sud) and 
regions (ARS-Agenzia Regionale di Sanità Toscana, Regione Lombardia) was established in 
order to pool information and discuss the comparability of data. It was thus possible to obtain 
information from four regions, one located in Northern Italy (Lombardy), one in Central Italy 
(Tuscany) and two in the South (Abruzzi and Apulia). The four Italian regions represents more 
than one third (i.e. around 19 million people) of the Italian population. The coverage is larger 
than in all the other studies on death related costs (i.e. a lot of studies focus only on people 
living in very limited areas or enrolled in a single health fund) so far published internationally. HEALTH COSTS PRIOR TO DEATH | 3 
Table 1. Countries of the study and type of analysis  
Country   Kinds of analyses 
US Descriptive  and  projections 
Canada Descriptive 
Switzerland Econometric 
Germany Econometric,  descriptive and projections 
Italy Descriptive  and  projections 
Spain Descriptive 
Austria Descriptive  and  projections 
UK  Econometric, descriptive and projections 
Denmark Descriptive  and  projections 
The Netherlands  Descriptive and projections 
France Descriptive 
Sweden Descriptive  and  projections 
OECD countries  Projections 
Source: Author’s compilation. 
The analysis reported in this paper used a two-step method: in the first step, databases of 
information on healthcare consumption at individual level were assembled. In the second step, 
these databases – which contained demographic information on patients – were used to compute 
health expenditure according to age and gender, and health expenditure prior to death (i.e. in the 
last 12 months) by age and gender. For this purpose, the available administrative databases on 
healthcare consumption were linked to the death abstracts databases.  
Concerning the procedure for the data linkage, for Lombardy and Tuscany the fiscal numbers 
were used as subject identifiers (i.e. the error percentage is very low). For Abruzzi and Apulia a 
statistical linkage method was adopted, based on fiscal numbers and other variables, as name, 
surname, birth data and sex. Defined rules to merge these variables have been followed. In this 
case the error percentage is estimated to be about 5%. 
To compute healthcare expenditure in the last year prior to death, the subjects were 
distinguished into ‘cases’ (subjects deceased in year 2000) and ‘controls’ (survivors, i.e. 
subjects alive on 1.1.2001 and surviving for at least 12 months after hospital admission). 
Hospital admissions in the last year of life of subjects deceased in 2001 were excluded. This 
meant the exclusion of subjects admitted in 2000 within 12 months before death and deceased in 
2001.  
The administrative databases on healthcare consumption at individual level in Italy are available 
on hospital care and (only in some regions) on outpatient specialist care, rehabilitation services 
either in outpatient departments or at home, nursing homes and pharmaceutical care. These 
databases contain information on patient characteristics, type of health services received (the 
procedures and therapies charged to the Regional Health Service) and health service tariffs.  
Given the differing availability of data and their varying quality, it was possible to work with 
data of some regions for hospital care and to carry out only rather preliminary case studies on 
pharmaceutical and specialist care in Tuscany. It should be borne in mind that, according to the 
region, hospital care in Italy accounts for between 43% and 49% of the healthcare budget. 
The data on hospital care were obtained from the regional Discharge Abstracts Database (years 
1999, 2000 and 2001). Tariffs are only a proxy for healthcare costs and expenditure, but they 4 | ENEPRI POLICY BRIEF NO. 5 
were the only available information that could be used at patient level. Per-day tariffs – useful 
for computing monthly costs – were calculated as the admission cost divided by the number of 
days in hospital, although the costs in fact vary during the stay.  
The data on mortality were taken from the Regional Death Abstracts database of causes of death 
(Tuscany), the Local Health Authorities database (Lombardy) and a national database compiled 
by the national statistical institute
  - ISTAT
 1  (Abruzzi and Apulia). The demographic data, 
which were provided by ISTAT, included all residents in the regions. 
Even if there are some concerns about the reliability of individual data, mainly in the two 
southern regions, the databases adopted are the best source currently available.  
Main results 
The literature review shows that decedent costs are much higher than survivor costs, according 
to most descriptive studies. The ratio between expenditures of these two groups on healthcare 
has an age-decreasing character, as do the costs in the last period of life. A different age pattern 
can be observed in long-term care, however, despite the fact that a shortage of data has led to a 
paucity of studies that also analyse long-term care. 
Econometric studies confirm that proximity to death, rather than age, is the main driver of 
health-care spending, at least for the over-65 age groups. Yet there is still disagreement on the 
effect of age, once time to death has been controlled for (as well as on the different 
methodologies used by certain authors). Concerning the impact of age on death costs, some 
studies show an ‘age neutrality’ of death costs; others suggest a constant age-decreasing profile; 
and still others report a ∩-shaped relationship between age and health-care costs in the last 
period of life. 
At the individual level, the major importance of death costs is confirmed. Projection studies 
include the differences in per capita costs between survivors and decedents (although they use 
different methods to define these groups) and seek to predict the growth in aggregate health-care 
spending related to ageing. The amount of the reduction in spending once death costs have been 
included in the projection differs significantly among studies, but they all confirm that including 
death costs reduces the concern that health-care spending will increase exorbitantly in the 
future. It can consequently be concluded with certainty that age alone is not a good predictor of 
rises in health-care spending, and that proximity to death must also be used as a predictor of 
health-care expenditure. 
The case of Italy is quite consistent with most other empirical evidence. Average hospital 
expenditure per survivor is €406 in Lombardy, €419 in Tuscany, €568 in Abruzzi and €460 in 
Apulia, as the one on deceased reaches €5,593 in Lombardy, €5,868 in Tuscany, €5,770 in 
Abruzzi and €5,481 in Apulia. While the survivors’ per capita expenditure-profile by age for the 
four regions are J-shaped, as we expected from the literature, costs near death diminish after a 
certain age. There are wide fluctuations, which progressively diminish, until about the age of 
55-59, due to the small number of observations made on young ages and the large share of 
deaths caused by accidents. What happens after middle age is much more interesting: 
expenditure constantly diminishes, and the per capita amounts of the various regions tend to 
coincide. Expenditure on the deceased aged 90 or over is 26% of that for 55-59-year-old men, 
18% for women. Summarising per capita expenditure trends on survivors and deceased for all 
regions, we calculate that expenditure on the deceased aged 90 or over is 26% of that for 55-59-
                                                      
1 ISTAT, Mortalità per causa nelle regioni, 2000, 2001 and 2002. HEALTH COSTS PRIOR TO DEATH | 5 
year-old men, 18% for women. This percentage tends to increase as age decreases: it is 51% at 
80-84 years for men (42% for women), and 81% (men) at 70-74 years (70% for women).  
The ratio between per capita expenditures on deceased and survivors by age varies, for all ages, 
between 10 and 14 (12-16 for men and 8-12 for women) among the regions.
2 Like the numerator 
(deceased expenditure), and for the same reasons, the ratio shows numerous fluctuations for 
young ages. We observe a downward trend in over 40-year-olds. The ratio is one or two for over 
ninety-years-olds, whereas for the 35-39 age group it varies between 36 and 43 for men and 
between 21 and 40 for women (see Figure 1). 
Figure 1. Hospital expenditure by age and gender of survivors and of deceased, all regions 
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Different methods, datasets and hypotheses notwithstanding, the size of the average ratio and of 
the ratio at old ages (see Table 2) is rather similar to that found for other countries, for instance 
the Netherlands
3 (11.5 for all ages), USA
4 (about 9 for 70-74 years, 7 for 75-79, 5 for 80-84, 4 
for over 85), Spain
5 (about 9 for 70-74 years, 7 for 75-79, 6 for 80-84, 5 for over 85, but for all 
ages the ratio is 24). 
Per capita hospital expenditure on the deceased, for all ages, constantly increases from the 
twelfth to the last month before death, and the rise is exceptionally steep in the final month. At 
                                                      
2 Using data from Taroni & Nobilio (2004), we also calculated the Emilia-Romagna ratio, which is about 
14 (women and men).
 
3 Polder & Achterberg (2004).
 
4 Lubitz & Riley (1993) and Calfo et al. (2003).
 
5 Ahn et al. (2003).
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the youngest ages (1-44), expenditure is much higher for deceased women than for men. Yet 
inspection on all ages shows greater expenditure for men than for women. 
In the last month before death, per capita expenditure for all ages is just over €2,000 for men 
and €1,500 for women in Apulia, between €2,000 and €2,500 for men and between €1,500 and 
€2,000 for women in Abruzzi and Tuscany, and between €3,000 and €3,500 for men and 
between €2,000 and €2,500 for women in Lombardy.  
In order to get a rough idea, we carried out a very preliminary survey on prescription drugs and 
outpatient specialist care in Tuscany, adopting for the purpose the same data linkage method as 
used for the hospital databases. The preliminary results on specialist and pharmaceutical 
expenditure confirm the death costs trends found for hospital expenditure, even if with different 
rates of change. 
Table 2. Per capita hospital expenditure ratio deceased/survivors by age and gender 
 
Discussion/conclusions  
Our study confirms the results of recent research on heathcare costs prior to death carried out in 
other OECD countries.  
It also suggests that Italian institutional and socio-economic regional differences are not 
particularly significant with regard to the issue under discussion: although the four regions 
examined are situated in three different macro-areas, they have similar patterns of prior-to-death 
per capita expenditure profiles by age. The ratio between deceased and survivor expenditure per 
age also displays a similar trend in the four regions, falling after 40 years and equalling one or 
two for over 90 years olds (the regional range is 10-14 for all ages). 
Nevertheless, our analysis has mainly concerned hospital expenditure. Hence, to deepen our 
knowledge of the question, it would be useful to extend our analysis to other items of heath 
expenditure. The first results on Tuscany could be checked and compared with those for the 
other regions. We expect confirmation for specialist and pharmaceutical care. By contrast, long-
term care is not likely to show a characteristic pattern of costs near death, since the 
 
 
Age Men  Women All  Men  Women All Men Women All Men Women All
 1-4 77,1  67,8 71,8 50,1 151,6 101,3 56,6 63,0 58,8 74,0  91,9  81,8
 5-9 109,9 144,4 124,1 12,1 204,4 102,5 71,8 165,9 113,5 0,0 116,5 60,5
 10-14  88,7  134,1 109,0 12,5 125,4 73,2 99,5 51,0 81,5 14,0  60,0  32,8
 15-19  35,3  46,1 39,4 60,0 38,7 54,6 41,4 60,6 47,3 20,8  23,4  22,0
 20-24  30,0  30,3 29,6 22,7 41,4 27,4 27,6 44,0 28,8 7,1 5,0 6,3
 25-29  33,4  27,9 28,1 39,0 36,2 32,8 18,0 16,1 14,5 19,3  22,8  17,8
 30-34  32,3  28,6 26,8 36,8 24,6 27,3 29,9 22,5 23,0 8,1 45,0  25,0
 35-39  42,9  40,0 38,8 42,5 38,8 38,7 36,3 37,5 33,9 35,8  21,4  28,1
 40-44  38,4  44,6 40,3 36,9 54,5 43,9 31,7 31,6 31,2 25,0  21,0  22,9
 45-49  29,1  31,4 30,1 43,8 44,0 44,2 29,1 26,7 28,0 24,9  23,8  24,3
 50-54  21,4  28,0 24,0 27,0 35,2 30,3 18,4 23,9 20,5 16,1  14,4  15,8
 55-59  16,9  25,5 20,2 21,2 28,5 24,4 15,5 18,6 17,0 14,1  18,0  15,8
 60-64  11,9  17,4 14,3 14,5 21,2 17,4 11,5 12,9 12,5 10,0  14,6  11,9
 65-69  8,1 12,4 10,0 10,9 15,5 13,0 7,7 9,3 8,6 7,4 8,9 8,3
 70-74  6,1 8,6 7,4 7,6 9,9 8,9 5,5 6,8 6,3 5,6 6,6 6,3
 75-79  4,5 5,6 5,2 5,4 6,5 6,1 3,9 4,1 4,2 3,9 4,6 4,4
 80-84  3,4 3,8 3,8 3,7 4,3 4,1 2,9 3,2 3,2 3,0 3,2 3,2
 85-89  2,5 2,8 2,7 3,0 2,9 3,0 1,8 1,9 1,9 2,2 2,1 2,2
 90+ 1,8 1,8 1,8 1,9 1,8 1,8 1,3 1,2 1,3 1,5 1,3 1,4
 All ages 15,9  11,7 13,8 16,1 12,0 14,0 14,2 9,7 11,9 11,7  8,5 10,2
Apulia Lombardy  Tuscany Abruzzi
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concentration of the bulk of expenditure in the last months (years) is due to the onset of acute 
diseases.  
A second step to gaining better understanding of the profile of health expenditure per age would 
be to examine the split between survivors and the deceased over several years. However, it is 
not possible to perform this analysis with Italian data since they are not available. In fact, 
administrative databases of healthcare consumption at individual level are not available for 
many years in the past, and the older databases are generally not as complete and reliable as the 
more recent ones. 
From a microeconomic point of view, distance to death is an important factor in explaining the 
concentration of health expenditure on certain groups of people. In this regard, it would be 
useful to analyse the healthcare treatments and costs due to certain chronic conditions and 
terminal pathologies, and to identify and promote cost-effective practices. 
From the macroeconomic point of view, the distinction between ‘old age costs’ (healthcare 
expenditure due to the ageing of the population) and ‘death costs’ (healthcare expenditure due to 
the event of dying) can be used as the basis for long-term healthcare expenditure projections.  
In fact, the results of AHEAD WP7 were used by the Ragioneria Generale dello Stato
6 (RGS) in 
Italy and by the Working Group on Ageing Populations (AWG) and the DG ECFIN at an 
European level to compute the death related costs scenario, respectively in the Annual Update 
of the Italian Stability and Convergence Programme (annually assessed by the European 
Council and by the European Commission) and in the new 2006 European official projections 
on the evolution of age related expenditures up to 2050.  
In light of our new multi-regional data, it is possible to confirm that health spending is likely to 
grow to a lesser extent than expected when account is taken of costs near death. RGS, applying 
our data on the hospital expenditure and adopting a dynamic age-related expenditure profile for 
the other expenditure components, shows a projected health expenditure/PIL ratio for Italy 0.5 
points lower by 2050 than in the base case scenario. The AWG report – in its ‘death costs 
scenario’ based on a costs-profile by age and survival status calculated as an unweighted 
average of available European datasets, including the one on Italy provided by AHEAD WP7 – 
shows an EU healthcare expenditure (as % of GDP) by 2050 0.4 points lower compared to the 
pure ageing scenario (0.3 for Italy). 
                                                      
6 The State General Accounting Department (Ragioneria Generale dello Stato - RGS) is the central 
control body that supports the Parliament and the Government on budget policies, processes and 
procedures. The primary institutional objective of the Department is to guarantee the correct 
administration and the rigorous planning and programming of public resources. The RGS is responsible 
for the consistency and reliability of national accounts and for the assessment and the analysis of public 
expenditure trends. It has the responsibility of drawing the annual national budget draft, including 
associated adjustment and variation measures, the multi-annual national budget and also the Finance Bill 
and related provisions. The Department's functions have been recently extended in order to allow a more 
exhaustive monitoring and analysis of expenditure trends, specifically regarding internal growth and 
Stability Pact targets (cfr.the website http://www.rgs.mef.gov.it/ENGLISH-VE/about-us/index.asp). 8 | ENEPRI POLICY BRIEF NO. 5 
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